In summary, our study demonstrates that intranasal administration of Apelin-13 effectively improves cognitive impairment in an STZ-induced AD model by enhancing synaptic plasticity and modulating the Nrf2-HO1 pathway to reduce oxidative stress. The gene discussed is APLN; the disease is Cognitive impairment.